Michael Mollerus
Lawyers
Filters
Venture Global $1.75 billion IPO
We advised Venture Global on its IPO and NYSE listing
Emerson $7.2 billion acquisition of remaining outstanding shares of AspenTech
We are advising Emerson on its acquisition
Royalty Pharma $1.1 billion acquisition of its external manager and $3 billion share repurchase
We are advising Royalty Pharma on the transaction
Teoxane proposal to acquire Revance Therapeutics
We are advising Teoxane on the proposed acquisition
Paychex $4.1 billion acquisition of Paycor HCM
We are advising Paychex on the transaction
Aptiv corporate reorganization
We advised Aptiv on the corporate reorganization
Merchants Bancorp $230 million preferred stock offering
The depositary shares represent an interest in 7.625% fixed rate non-cumulative perpetual preferred stock
Shyft Group merger with Aebi Schmidt Group
We are advising Shyft Group on the transaction
Lockheed Martin $1 billion senior notes offering
The investment-grade notes are due 2031 and 2055
Coty $300 million tender offer
The offer applies to certain senior notes due 2026